Clindaclear Oral Solution
كلينداكلير محلول فموي
Pharmaceutical
Clindaclear Oral Solution is a lincosamide antibiotic containing Clindamycin HCl (equivalent to 25 mg base/ml), indicated for the treatment of necrotic enteritis, staphylococcosis, and toxoplasmosis.
Dosages
No dosage information available.
Withdrawal Periods
No withdrawal information available.
Indications
-
Indicated for the treatment of necrotic enteritis, staphylococcosis and toxoplasmosis.
Contraindications
-
Clindamycin or lincomycin hypersensitivity. Horses, ruminants. Concurrent use with chloramphenicol and macrolides.
Precautions
-
Care in animals with hepatic or renal impairment.
Side Effects
-
Occasional vomiting, diarrhea and inappetence.
Images
Documents
-
Download
Official Pharma Swede Product Specification
Datasheet
Active Ingredients
-
Clindamycin
25 mg/ml
Diseases
Related Products
No data available
Information has not been added yet.
Related Products By Active Ingredient
Companies
-
Pharma Swede Egypt
Manufacturer
Alternatives
No alternatives available.